Viz.ai Introduces Viz 3D CTA™ for Faster, Clearer Neurovascular Imaging and Real-Time Clinical Decisions

Viz.ai Launches Viz 3D CTA to Enhance Imaging and Speed Up Clinical Decision-Making SAN FRANCISCO -- Viz.ai, a leading provider of AI-driven disease detection and care coordination, has announced the launch of Viz 3D CTA, a revolutionary solution that transforms computed tomography angiography (CTA) scans into high-resolution, AI-enhanced 3D images. This new tool aims to accelerate and improve the visualization of neurovascular conditions, enabling care teams to make faster and more accurate clinical decisions. The technology behind Viz 3D CTA is designed to convert traditional 2D CTA images into detailed 3D models, enhancing the clarity and detail of the scans. By providing these enhanced visualizations, Viz 3D CTA helps doctors and healthcare professionals better understand the complexities of patients' vascular systems, particularly in cases involving stroke, aneurysms, and other cerebrovascular diseases. The integration of this advanced imaging within the Viz.ai platform ensures seamless access, allowing medical teams to interact with the 3D images in real-time. One of the key features of Viz 3D CTA is its ability to automate the conversion process, significantly reducing the time required for image processing and interpretation. Traditionally, converting 2D CTA scans to 3D images involves a manual and time-consuming procedure, often leading to delays in diagnosis and treatment. With Viz 3D CTA, this step is automated, ensuring rapid availability of high-quality 3D visualizations that can be crucial in emergency situations. Dr. Krishna Yeshwant, a neurosurgeon and one of Viz.ai's advisors, highlighted the potential impact of this technology. "Viz 3D CTA has the potential to transform how we diagnose and treat cerebrovascular conditions," he said. "By providing real-time, detailed 3D images, we can more accurately assess the severity of the condition and plan the most effective intervention." In addition to improving diagnostic accuracy, Viz 3D CTA also enhances collaboration among healthcare providers. The platform's real-time capabilities allow multiple specialists to view and discuss the same 3D images simultaneously, fostering a more coordinated and efficient approach to patient care. This is especially beneficial in multidisciplinary settings where neurologists, neurosurgeons, and radiologists work together to develop treatment plans. Viz.ai's commitment to advancing AI technology in healthcare extends beyond just imaging. The company also offers a suite of tools for intelligent care coordination, including alert systems that notify relevant medical teams when a patient's scan indicates a high-priority condition. These alerts can be critical in reducing the time from imaging to intervention, ultimately improving patient outcomes. The launch of Viz 3D CTA comes at a time when the importance of speedy and accurate diagnosis in neurovascular emergencies is increasingly recognized. According to a recent study published in the Journal of Neurosurgery, faster diagnosis and treatment can significantly reduce the damage caused by strokes and improve patient survival rates. Viz 3D CTA is poised to play a pivotal role in achieving these goals by streamlining the imaging process and providing clinicians with powerful visual aids. Viz.ai CEO, Chris Mansi, emphasized the company's vision and the significance of Viz 3D CTA. "Our mission is to leverage AI to transform the way we manage and treat critical diseases," Mansi said. "Viz 3D CTA is a major step forward in this direction, offering a transformative tool that can revolutionize clinical workflows and patient outcomes in neurovascular care." The technology has already been tested in several clinical settings, with promising results. Dr. Yeshwant mentioned a case where a patient with a severe intracranial aneurysm was diagnosed using Viz 3D CTA. "The 3D images provided by Viz 3D CTA allowed us to quickly and precisely identify the location and size of the aneurysm, which was critical in planning the surgery," he explained. "This not only saved time but also potentially saved the patient's life." The integration of Viz 3D CTA into the broader Viz.ai platform also means that hospitals and clinics using Viz.ai's solutions will have a unified system for managing imaging data and coordinating care. This can lead to better patient management and reduced operational costs, as medical teams can focus more on patient care rather than administrative tasks. As Viz 3D CTA continues to gain traction, Viz.ai is dedicated to expanding its reach and improving its capabilities. The company plans to conduct further research and clinical trials to validate the effectiveness of the technology and to explore additional applications in other areas of medical imaging. In summary, Viz 3D CTA from Viz.ai represents a significant advancement in the field of neurovascular imaging. By automating the conversion of 2D CTA scans to 3D images, the technology not only speeds up the diagnostic process but also improves the accuracy and clarity of the results. This innovation promises to enhance patient care, foster better collaboration among healthcare providers, and ultimately contribute to better health outcomes for those suffering from critical cerebrovascular conditions.